Acta Oncologica
Volume 62, 2023 - Issue 12
Original Articles: Clinical Oncology
Improved overall survival for Stage III NSCLC patients treated with curative-intended therapy from 2010 to 2018–a cohort study in Denmark
Peter Meldgaarda Institute for Clinical Medicine, Department of Oncology, Aarhus University Hospital, DenmarkCorrespondence[email protected]
https://orcid.org/0000-0002-5788-4463View further author information
https://orcid.org/0000-0002-5788-4463View further author information, Michael Kristensenb AstraZeneca, Copenhagen, Denmarkhttps://orcid.org/0009-0004-3772-2311View further author information
https://orcid.org/0009-0004-3772-2311View further author information, Simona Contec AstraZeneca, Stockholm, Swedenhttps://orcid.org/0009-0007-6992-1114View further author information
https://orcid.org/0009-0007-6992-1114View further author information, Klaus Kaae Andersend Omicron ApS, Copenhagen, Denmarkhttps://orcid.org/0000-0003-3573-092XView further author information
https://orcid.org/0000-0003-3573-092XView further author information, & Ebbe Meldgaardf Department of Oncology, Aarhus University Hospital, Denmarkhttps://orcid.org/0009-0001-5889-7709View further author information
https://orcid.org/0009-0001-5889-7709View further author information